A $25m gift from Yong Loo Lin Trust to help fight cancer

Similar documents
BETTER ACCESS TO SPECIALIST DENTAL CARE AND EXPANSION OF DENTAL EDUCATION WITH NEW NUHS NATIONAL CENTRE

29 October For immediate release MEDIA RELEASE

PRESS RELEASE FOR IMMEDIATE RELEASE SINGAPORE INSTITUTES COLLABORATE WITH SAMSUNG MEDICAL CENTER TO IMPROVE TREATMENT OF LIVER CANCER

RESEARCHERS FROM A*STAR AND NUS IMPLICATE HOUSE DUST MITES AS THE MAIN CAUSE OF RESPIRATORY ALLERGIES IN SINGAPORE

A*STAR AND NUS RESEARCHERS SCORE BREAKTHROUGH IN DEVELOPING UNLIMITED NUMBER OF PURE INSULIN-PRODUCING CELLS

New national centre for treatment of cancer opens at NUH

MEDIA RELEASE FOR IMMEDIATE RELEASE 28 SEPTEMBER 2017

The changing demand of cancer services in Hong Kong can be summarized as follows:

a case to support THE HEART & VASCULAR CENTER

NTU and Changi General Hospital to train medical practitioners in ageing and sports-related injuries

SINGAPORE SCIENTISTS DISCOVER NEW PATHWAYS LEADING TO CANCER PROGRESSION

SINGAPORE SCIENTISTS DISCOVER METABOLIC DRUG CAN TREAT TERMINAL WEIGHT LOSS IN CANCER PATIENTS

An Extraordinary Resource for Cancer Care

Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC

Sustain and Seize Cancer Research Opportunities

MULTINATIONAL HEART FAILURE STUDY SHOWS HIGH PREVALENCE OF CORONARY ARTERY DISEASE, HYPERTENSION AND DIABETES IN ASIAN PATIENTS

A*STAR AND NUS LAUNCH JOINT CENTRE TO ADVANCE RESEARCH ON NUTRITION, EARLY DEVELOPMENT AND METABOLIC DISEASES

National University Hospital

Closing Press Release IDEM Singapore International Dental Exhibition and Meeting IDEM Singapore 2016 Concludes on a Successful Note

With your help, our goal is to protect millions more against serious illness through the development of new vaccines and other preventions.

UC HEALTH RESEARCH INSTITUTE STRATEGIC PLAN

London Regional Cancer Program

Singapore Cancer Society, Breast Cancer Foundation & National Healthcare Group Diagnostics Jointly Launch a Community Mammobus Programme

MEDIA RELEASE FOR IMMEDIATE RELEASE 11 SEPTEMBER 2017

Embargoed until 2.30pm on 27 August 2016, Singapore Time PRESS RELEASE

DEPARTMENT OF ONCOLOGY STRATEGIC PLANNING SURVEY THEMES

The Ayrshire Hospice

UNRAVELING THE MYSTERY BEHIND HIV/AIDS

SAVING LIVES: ACHIEVING MORE

BACK TO SPINAL RESEARCH

R e s e a r c h S t r a t e g y

Another Record Year for Bayer HealthCare Pharmaceuticals in Asia Pacific

LEADERSHIP CHANGES AT THE NATIONAL HEALTHCARE GROUP Succession Plan aligned to Integrated care for Singaporeans

Innovator Case Studies: Oncology Networks

Planning Case Study. Barbara Ann Karmanos Cancer Institute McLaren Health Care Detroit, Michigan

AUSTRALIA'S ONLY DEDICATED ACADEMIC DEPARTMENT OF NEUROSCIENCE.

CELEBRATING 169 YEARS OF TRADITION AND TRANSFORMATION IN HEALTHCARE RESEARCH

I. Introduction. II. Program Description

Making a Difference. Highest quality care. Education. Research. Innovation. OUR MISSION:

PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM

Mental Health Matters

Planning Case Study. Barbara Ann Karmanos Cancer Institute McLaren Health Care Detroit, Michigan

Cardiothoracic Surgery Residency Program

Allied Healthcare Professionals Module

Academic Clinical Fellowship in Respiratory Medicine

UC San Diego HIV Institute Creating a Future Without HIV/AIDS

Pain and Palliative Care Institute

Pediatrics Residency Program

BRANCHED-CHAIN AMINO ACIDS FOUND TO REGULATE THE DEVELOPMENT AND PROGRESSION OF CANCER

Parkinson s Research and the New Centre for Brain Health at UBC. Case for Support The University of British Columbia Faculty of Medicine

British Society for Immunology. Corporate Membership Packages

Walgreens. Specialty Pharmacy Marketing Video

Digestive & Metabolic Diseases

HEALTHSTREAM LIVING LABS IN ACTION

WOLFSON FERTILITY CENTRE. Wolfson Fertility Centre

Thomas C. Wilmot, Sr. Judy Wilmot Linehan

University of Cincinnati Heart, Lung & Vascular Institute

Parkinson s Institute and Clinical Center Appoints Anthony Santiago, M.D., Neurologist and Movement Disorders Specialist as Chief Medical Officer

Schulich Dentistry STRATEGIC PLAN Schulich School of Medicine & Dentistry, Western University

International collaboration to develop inhaled form of oxytocin to manage bleeding after childbirth in developing countries

Human Health Using nuclear techniques to improve health around the world

THE UNIVERSITY OF IOWA COLLEGE OF. At a Glance

New CyberKnife M6 Service at HKSH for Cancer Patients Shorter Treatment Time, Fewer Side Effects and Improved Patient Outcomes

ADOLESCENT MEDICINE SUBSPECIALTY RESIDENCY/FELLOWSHIP PROGRAM DESCRIPTION

Strategic Directions

Palliative Care in Public Health System

Faculty Wellness Program. Positive, collegial communication and support for Feinberg faculty members

Improving services for upper GI (OG) cancer Application template (Version 2)

SUMMARY REPORT 1. EXECUTIVE SUMMARY. Program provider. University of Sydney

Ready for a CRO That Values Performance Over Promises? CHALLENGE. At Clinipace, it s personal.

Seattle Cancer Care Alliance Updates, Relaunches Brand Redesigned logo reiterates founding partner strength, patient care commitment

Bayer and Regeneron start clinical Phase III trial to extend ophthalmology research & development program for VEGF Trap- Eye in Asia

DONOR RECOGNITION PROGRAM

NEW COALITION AIMS TO HELP PREVENT MISUSE, ABUSE AND DIVERSION OF ADHD MEDICATIONS Coalition to Focus Efforts on College Students

Roche provides update on phase III study of TECENTRIQ (atezolizumab) in people with previously treated advanced bladder cancer

Service Improvement - Strategic. Service Improvement - Strategic. Regional Oncology Communications and Health Promotions

Nationwide study on connection between positive mental health and physical health to improve wellness in Singapore

Advanced. Bronchoscopy & Pleuroscopy Course. 4th 7th July 2018 Academia, Singapore General Hospital 20 College Rd, Singapore

Good News Encino! California s Best health care for kids is right in your backyard.

Genitourinary Oncology Fellowship for Physicians in China A Multidisciplinary Clinical and Research Training Opportunity at Massachusetts General

Murtha Cancer Center The DoD Cancer Center of Excellence

Excellence Without Exception

UT Health Physicians. Carlos A. Rosende, M.D., F.A.C.S. Executive Vice Dean for Clinical Affairs Executive Director, UT Health Physicians

Research goal is to identify better diagnostic, vaccine and treatment targets for chlamydia and gonorrhea

MEDIA RELEASE FOR IMMEDIATE RELEASE. 15 September 2014

LEADERSHIP PROFILE. CURE Childhood Cancer believes that childhood cancer can be cured in our lifetime. -- CURE Childhood Cancer s Vision

The Center on Aging unites aging-related research, education, and clinical programs at the University of Utah to help people lead longer and more

Developing & Commercializing Targeted Small Molecule Drugs in Cancer

Who we are. We envision a world where high quality eye health and vision care is accessible to all people.

Factsheet on Children s Palliative Care at Jersey Hospice Care

STRATEGIC PLAN

The University of Buckingham DENTAL INSTITUTE

Immunocore and MedImmune announce new collaboration to conduct immuno-oncology combination trials in melanoma

COVER SHEET. Accessed from Copyright 2003 Australasian Medical Publishing Company

Our Colorectal Surgery Team

Here for You When You Need Us

REPORT. A Model Clinical Trials System for the 21st Century

Your Excellency, Mr Paul Madden, British High Commissioner, Singapore. It is a great pleasure to welcome all of you to the Biopolis for this two-day

Integration of palliative care into oncology

UCSF Osher Center for Integrative Medicine. Your life, your health, your choice.

Transcription:

Press Release For immediate release 28 March 2013 A $25m gift from Yong Loo Lin Trust to help fight cancer NUS Yong Loo Lin School of Medicine to work with National University Cancer Institute, Singapore to develop new models of cancer care through research and education SINGAPORE The National University of Singapore (NUS) Yong Loo Lin School of Medicine has received a $25 million gift from the Yong Loo Lin Trust to work with the National University Cancer Institute, Singapore (NCIS) to develop new models of cancer care through research and education. This gift is in addition to the $100 million gift from the Trust to the School of Medicine in 2005 which transformed the School s research and scholarship in several diseases, including cancer. The new gift is meant for the development of better ways to prevent, screen, diagnose, and treat cancer at NCIS, which is located at the National University Hospital (NUH). In appreciation and recognition of the Trust s latest gift, NCIS s upcoming facility at the hospital s soon-to-open NUH Medical Centre will be named the Yong Siew Yoon Wing. Ms Yong is a daughter of the late Dr Yong Loo Lin, a physician-turned-businessman who was a strong proponent of education. The gift will attract a matching grant from the Singapore Government, bringing the total funding up to $50 million. Yong Loo Lin Trust pivotal in shaping medicine, music education Acknowledging what he said was yet another transformational gift from the Yong Loo Lin Trust, NUS President Professor Tan Chorh Chuan expressed the University s deep appreciation for the continuing support that the Trust is giving to NUS. NUS has benefitted tremendously from the beneficence of the Yong Loo Lin Trust over the years; with gifts in 2003 and 2008 totaling $50 million to the Yong Siew Toh Conservatory of Music, then to the Medical School in 2005 with a gift of $100 million, and now, with this gift of $25 million to advance cancer research, 1

education and care in Singapore through the Medical School. The Yong Loo Lin Trust has truly been pivotal in shaping the future of education in medicine and music in Singapore. We are deeply grateful and honoured by this gift. The cancer burden in Singapore NUS Vice-Provost for Academic Medicine and Director of NCIS, Professor John Wong, Isabel Chan Professor in Medical Sciences, said the School has been investing its research and education efforts in key diseases of significance to Singapore. One such disease is cancer, the leading cause of death among Singaporeans. With increased life expectancy, it is estimated that one out of three people will be afflicted with cancer in their lifetime. Many major milestones in Singapore s cancer history have resulted from pioneering work done by NUS and NUH faculty over the decades. Today, cancer research and education efforts on campus are spearheaded by NCIS and the Cancer Science Institute of Singapore (CSI) at NUS. Cancer is a major disease burden worldwide. Globally, approximately 12.7 million people are diagnosed with the disease every year and an estimated 7.6 million die from it. Almost fifty-two thousand new cases were diagnosed among Singapore residents between 2006 and 2010. Colorectal cancer is now the most common cancer among men, accounting for almost one in five of all new cancers. Among women, it is breast cancer, accounting for almost one in three new cancers. We need to develop better ways to prevent, screen, diagnose and treat cancer through research and education. We cannot expect other countries to develop solutions for our problems, Professor Wong added. Gift to support ongoing and new cancer research at NUS and NCIS The gift from the Yong Loo Lin Trust will help fund cancer research and education. It will enable clinicians and clinician-scientists in NCIS to work closely together with relevant counterparts across Singapore and internationally to find useful and cost-effective treatments for cancer patients living here, while also providing seed-funding for clinical trials. These high quality research projects will focus on a range of cancer-related problems, which will benefit Asian patients. The key clinicians and scientists, several of whom hold appointments in NCIS and jointly in the NUS Yong Loo Lin School of Medicine, working on important cancer-related research projects, include: Associate Professor Yeoh Khay Guan, Dean of the Yong Loo Lin School of Medicine. He is leading a multi-institutional team that has been able to save lives, detecting gastric cancer at Stage 0, sparing patients surgery, chemotherapy and radiation. Associate Professor Goh Boon Cher, who leads NCIS s drug development programme, and has placed Singapore on the global map for cancer drug development in Asian patients. 2

Associate Professor Lee Soo Chin, who is developing molecular signatures to predict which drugs work best for individual patients with breast cancer. Associate Professor Chng Wee Joo, who has pioneered work in the treatment of myeloma, a form of bone marrow cancer. Associate Professor Allen Yeoh, who has developed molecular markers to tailor chemotherapy for children with leukemia, improving clinical outcomes in Singapore and collaborating centres in Malaysia. NCIS is also the headquarters of the Cancer Therapeutics Research Group (CTRG), a joint research group comprising nine institutions in Singapore, Australia, Hong Kong, Taiwan, and Korea. The group collaborates on clinical trials to develop new therapeutic strategies for cancers common to the Asia-Pacific region. Holistic care for cancer patients When the Yong Siew Yoon Wing at the 72,000 square metre NUH Medical Centre is ready, NCIS patients will be able to benefit from a one-stop facility for holistic care. The Centre will integrate physician consultations, family and patient counselling, chemotherapy infusion, radiation therapy, diagnostic imaging, and a health resource centre in a single location. Facilities and services for imaging, dietetics, pharmaceutical dispensing and clinical laboratories will be located close to clinical areas to minimise movement and the time taken to access care, effectively expressing the National University Health System s (NUHS) plan for patients to receive cost-effective care in the most appropriate setting with coordinated, seamless and efficient management through close coordination between specialties. NCIS s location within the 20-storey NUH Medical Centre alongside other NUH specialist medical clinics makes this a reality when it opens in due course. Then, space vacated by these clinics at the NUH s Main Building will be upgraded and reconfigured to accommodate new patient care facilities. Ambulatory teaching setting enhances medical education Provisions have also been made to create a conducive, learning environment for medical students and trainees. This ambulatory teaching setting, in which we move away from conventional teaching in the wards to the clinics, will change traditional medical training. It will enable medical students and residents to learn to tackle real-life problems and gain the clinical experience and knowledge they need to become effective doctors, said Associate Professor Benjamin Ong, Chief Executive of NUHS and Senior Vice-President (Health Affairs), NUS. This new teaching practice is also aligned with the Medical School s newly revised curriculum, which aims to lay a firm foundation in the basic medical sciences while providing students with high quality clinical experiences through early patient exposure from the beginning of their fiveyear medicine course. - Ends- 3

About the National University of Singapore (NUS) A leading global university centred in Asia, the National University of Singapore (NUS) is Singapore s flagship university which offers a global approach to education and research, with a focus on Asian perspectives and expertise. NUS has 16 faculties and schools across three campuses. Its transformative education includes a broad-based curriculum underscored by multi-disciplinary courses and cross-faculty enrichment. Over 37,000 students from 100 countries enrich the community with their diverse social and cultural perspectives. NUS has three Research Centres of Excellence (RCE) and 23 university-level research institutes and centres. It is also a partner in Singapore s 5th RCE. NUS shares a close affiliation with 16 national-level research institutes and centres. Research activities are strategic and robust, and NUS is well-known for its research strengths in engineering, life sciences and biomedicine, social sciences and natural sciences. It also strives to create a supportive and innovative environment to promote creative enterprise within its community. For more information, please visit www.nus.edu.sg About the National University Health System (NUHS) The National University Health System (NUHS) groups the National University Hospital (NUH), the NUS Yong Loo Lin School of Medicine, the NUS Faculty of Dentistry and the NUS Saw Swee Hock School of Public Health under a common governance structure to create synergies to advance health by integrating clinical care, research and education. The enhanced capabilities and capacity will enable the NUHS to deliver better patient care, train future generations of health professionals more effectively and bring innovative treatments to patients through groundbreaking research. For more information about the NUHS, please visit www.nuhs.edu.sg About the NUS Yong Loo Lin School of Medicine (YLLSoM) Established in 1905, the NUS Yong Loo Lin School of Medicine was the first institution of higher learning in Singapore and the genesis of what would become the National University of Singapore. The School offers one of the finest undergraduate medical programs in the Asia Pacific region and commands international recognition and respect. In 2012, the School was ranked the top university in Asia for medicine and was placed 21st globally by Quacquarelli Symonds (QS). From Academic Year 2012/13, the School will admit 300 students to its medical undergraduate degree programme annually. The School strives to fulfill its tripartite mission of providing excellent clinical care, training the next generation of healthcare professionals, and fostering research that will transform the practice of medicine. It plays a pivotal role in producing future leaders in healthcare delivery, discovery and public service as well as in Singapore s Biomedical 4

Sciences Initiative and Singapore Medicine, an initiative to further develop as a regional medical center. The School s 16 departments in the basic sciences and clinical specialties work closely with the Alice Lee Centre for Nursing Studies and the Centre for Biomedical Ethics to ensure that teaching and research are aligned and relevant to Singapore s healthcare needs. For more information about the Yong Loo Lin School of Medicine, please visit http://medicine.nus.edu.sg/corporate/ About the National University Cancer Institute, Singapore The National University Cancer Institute, Singapore (NCIS) offers a broad spectrum of cancer care and management covering both paediatric and adult cancers, with expertise in prevention, screening, diagnosis, treatment, rehabilitation and palliative care. The Institute s strength lies in the multi-disciplinary approach taken to develop a comprehensive and personalised plan for each cancer patient and his or her family. NCIS draws on the expertise of its specialists in the fields of haematology-oncology, radiation oncology, gynaecologic oncology, paediatric oncology, surgical oncology, oncology nursing, oncology pharmacy, palliative care, pathology, radiology, medical specialties including gastroenterology and hepatology, infectious diseases, pulmonary and critical care, psychiatry, epidemiology and public health as well as other allied health sciences. NCIS s strength in research allows patients to access drugs and devices before they are commercially available. NCIS is also closely affiliated with the Cancer Science Institute of Singapore, National University of Singapore. For more information about the NCIS, please visit www.ncis.com.sg Press contacts: Ms Dawn Sim Assistant Director, NUHS Communications Tel +65 6772 3989; Mobile +65 92306006 Email: dawn_sim@nuhs.edu.sg Ms Jean Angus Senior Assistant Manager, NUHS Communications Tel +65 6772 3987 Email: jean_angus@nuhs.edu.sg 5